MedPath

HEMOLENS DIAGNOSTICS SP Z O O

🇵🇱Poland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities.

Completed
Conditions
Coronary Artery Disease
Stable Ischemic Heart Disease
First Posted Date
2021-03-02
Last Posted Date
2024-05-16
Lead Sponsor
Hemolens Diagnostics Sp. z o.o.
Target Recruit Count
450
Registration Number
NCT04777513
Locations
🇵🇱

American Heart of Poland, Centrum Kardiologii i Kardiochirurgii w Bielsku-Białej, Bielsko-Biala, Poland

🇵🇱

Oddział Kliniczny Kardiologii oraz Interwencji Sercowo-Naczyniowych Szpital Uniwersytecki w Krakowie, Cracovia, Poland

🇵🇱

The John Paul II Specialist Hospital in Cracovia, Cracovia, Poland

and more 8 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.